首页> 外文期刊>Italian Journal of Anatomy and Embryology >Neural crest derived niche of human dental pulp stem cells promotes peripheral nerve regeneration and remyelination in animal model of critical sized sciatic nerve injury
【24h】

Neural crest derived niche of human dental pulp stem cells promotes peripheral nerve regeneration and remyelination in animal model of critical sized sciatic nerve injury

机译:人牙髓干细胞的神经rest来源利基促进严重坐骨神经损伤动物模型的周围神经再生和髓鞘再生

获取原文
           

摘要

Peripheral nerve injuries are a commonly encountered clinical problem and often result?in long-term functional defects. The use of stem cells, easily accessible, capable of rapid expansion in culture as well as fully integrate into the host tissue and capable to differentiate in myelinating cells of the peripheral nervous system, represent an attractive therapeutic approach for the treatment of nerve injuries. Farther, stem cells sources sharing the same embryological origin of Schwann cells, might be considered a suitable tool. The aim of this study was to demonstrate the ability of a neuroectodermal sub-population of STRO-1+/c-Kit+/CD34+ hDPSCs (1, 2), most of which being positive for neural crest (P75NTR) and neural progenitor cells (nestin) markers, to differentiate into Schwann cells-like cells in vitro and to promote axonal regeneration in vivo. As a matter of fact, following culture in appropriate induction medium, STRO-1+/c-Kit+/CD34+ hDPSCs were able to commit towards Schwann cells express- ing P75NTR, GFAP and S100b. After transplantation in animal model of sciatic nerve defect, hDPSCs promoted axonal regeneration from proximal to distal stumps, providing guidance to newly formed myelinated nerve fibers, which led to functional recovery as measured by sustained gait improvement. Particularly, transplanted hDP- SCs engrafted into critical sized sciatic nerve defect, as revealed by the positive stain- ing against human nuclei, showed the expression of typical Schwann cells markers, S100b and GFAP. In conclusion this study demonstrates that STRO-1+/c-Kit+/CD34+ hDPSCs, associated to neural crest derivation, represent a promising source of stem cells for the treatment of demyelinating disorders and might provide a valid alternative tool for future clinical applications to achieve functional recovery after injury or peripheral neuropathies besides minimizing ethical issues.
机译:周围神经损伤是常见的临床问题,通常会导致长期的功能缺陷。干细胞易于使用,能够在培养中快速扩增以及完全整合到宿主组织中并且能够在周围神经系统的髓鞘细胞中分化,这是治疗神经损伤的一种有吸引力的治疗方法。此外,可以将具有相同雪旺细胞胚胎起源的干细胞来源视为合适的工具。这项研究的目的是证明STRO-1 + / c-Kit + / CD34 + hDPSCs的神经外胚层亚群(1、2)的能力,其中大多数对神经c(P75NTR)和神经祖细胞呈阳性( nestin)标记,可在体外分化为雪旺细胞样细胞,并在体内促进轴突再生。事实上,在适当的诱导培养基中培养后,STRO-1 + / c-Kit + / CD34 + hDPSCs能够对表达P75NTR,GFAP和S100b的雪旺细胞产生作用。在坐骨神经缺损动物模型中移植后,hDPSCs促进了轴突从近端到远端的轴突再生,为新形成的有髓神经纤维提供了指导,从而通过持续步态改善而导致功能恢复。尤其是,移植的hDP-SCs移植到了临界尺寸的坐骨神经缺损中,正如针对人类细胞核的阳性染色所揭示的那样,它表达了典型的雪旺细胞标记S100b和GFAP的表达。总之,这项研究表明,与神经c衍生相关的STRO-1 + / c-Kit + / CD34 + hDPSCs代表了用于治疗脱髓鞘疾病的干细胞的有希望的来源,并可能为将来的临床应用提供有效的替代工具,以实现损伤或周围神经病变后的功能恢复,同时将道德问题降至最低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号